Journey Change To Operating Activities from 2010 to 2026
| DERM Stock | USD 7.73 0.02 0.26% |
Change To Operating Activities | First Reported 2010-12-31 | Previous Quarter 699.3 K | Current Value 664.3 K | Quarterly Volatility 5.7 M |
Check Journey Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Journey Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.2 M, Interest Expense of 4 M or Selling General Administrative of 52.9 M, as well as many indicators such as Price To Sales Ratio of 1.55, Dividend Yield of 0.0 or PTB Ratio of 3.81. Journey financial statements analysis is a perfect complement when working with Journey Medical Valuation or Volatility modules.
Journey | Change To Operating Activities | Build AI portfolio with Journey Stock |
Evaluating Journey Medical's Change To Operating Activities across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Journey Medical Corp's fundamental strength.
Latest Journey Medical's Change To Operating Activities Growth Pattern
Below is the plot of the Change To Operating Activities of Journey Medical Corp over the last few years. It is Journey Medical's Change To Operating Activities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Journey Medical's overall financial position and show how it may be relating to other accounts over time.
| Change To Operating Activities | 10 Years Trend |
|
Change To Operating Activities |
| Timeline |
Journey Change To Operating Activities Regression Statistics
| Arithmetic Mean | 7,379,979 | |
| Geometric Mean | 3,939,548 | |
| Coefficient Of Variation | 76.63 | |
| Mean Deviation | 5,398,849 | |
| Median | 11,969,000 | |
| Standard Deviation | 5,655,254 | |
| Sample Variance | 32T | |
| Range | 11.3M | |
| R-Value | (0.86) | |
| Mean Square Error | 9T | |
| R-Squared | 0.74 | |
| Significance | 0.00001 | |
| Slope | (961,086) | |
| Total Sum of Squares | 511.7T |
Journey Change To Operating Activities History
About Journey Medical Financial Statements
Journey Medical investors utilize fundamental indicators, such as Change To Operating Activities, to predict how Journey Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Change To Operating Activities | 699.3 K | 664.3 K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of Journey Medical Correlation against competitors. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Will Biotechnology sector continue expanding? Could Journey diversify its offerings? Factors like these will boost the valuation of Journey Medical. Projected growth potential of Journey fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Journey Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.35) | Revenue Per Share | Quarterly Revenue Growth 0.205 | Return On Assets | Return On Equity |
Understanding Journey Medical Corp requires distinguishing between market price and book value, where the latter reflects Journey's accounting equity. The concept of intrinsic value - what Journey Medical's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Journey Medical's price substantially above or below its fundamental value.
It's important to distinguish between Journey Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Journey Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Journey Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.